The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Open accessAbstract
Adjuvant System 04 (AS04) combines the TLR4 agonist MPL (3-O-desacyl-4′-monophosphoryl lipid A) and aluminum salt. It is a new generation TLR-based adjuvant licensed for use in human vaccines. One of these vaccines, the human papillomavirus (HPV) vaccine Cervarix, is used in this study to elucidate the mechanism of action of AS04 in human cells and in mice. The adjuvant activity of AS04 was found to be strictly dependent on AS04 and the HPV Ags being injected at the same i.m. site within 24 h of each other. During this period, AS04 transiently induced local NF-κB activity and cytokine production. This led to an increased number of activated Ag-loaded dendritic cells and monocytes in the lymph node draining the injection site, which further increased the activation of Ag-specific T cells. AS04 was also found to directly stimulate those APCs in vitro but not directly stimulate CD4+ T or B lymphocytes. These AS04-induced innate responses were primarily due to MPL. Aluminum salt appeared not to synergize with or inhibit MPL, but rather it prolonged the cytokine responses to MPL at the injection site. Altogether these results support a model in which the addition of MPL to aluminum salt enhances the vaccine response by rapidly triggering a local cytokine response leading to an optimal activation of APCs. The transient and confined nature of these responses provides further supporting evidence for the favorable safety profile of AS04 adjuvanted vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Expression and function of Toll-like receptor on T cells
Xu, D., Komai‐Koma, M., & Liew, F. Y. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.04.019 · Cited by 92
RetractedImmunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,153
Monocyte-Mediated Defense Against Microbial Pathogens
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090326 · Cited by 1,123
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Muzio, M., Bosisio, D., Polentarutti, N., D’amico, G., Stoppacciaro, A., Mancinelli, R., van’t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,060
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M., & Muller, W. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80149-1 · Cited by 900
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
Control of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752
T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses
King, C., Tangye, S. G., & Mackay, C. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090344 · Cited by 632
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00718.x · Cited by 598
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Mechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Self-citationMolecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Self-citationFazilleau, N., McHeyzer-Williams, L. J., Rosen, H., & McHeyzer-Williams, M. G. (2009) · Nature Immunology · doi:10.1038/ni.1704 · Cited by 452
Faure, E., Thomas, L., Xu, H., Medvedev, A. E., Equils, O., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2018 · Cited by 451
Toll‐like receptor stimulation as a third signal required for activation of human naive B cells
Ruprecht, C. R., & Lanzavecchia, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535744 · Cited by 436
Bourke, E., Bosisio, D., Golay, J., Polentarutti, N., & Mantovani, A. (2003) · Blood · doi:10.1182/blood-2002-11-3355 · Cited by 384
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J., & Tobias, P. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5780 · Cited by 353
Qureshi, N., Takayama, K., & Ribi, E. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33836-5 · Cited by 336
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 332
Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8
Maelfait, J., Vercammen, E., Janssens, S., Schotte, P., Haegman, M., Magez, S., & Beyaert, R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071632 · Cited by 327
Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 312
Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., & Persing, D. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1129 · Cited by 256
Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells
Lenz, P., Day, P. M., Pang, Y.-Y. S., Frye, S. A., Jensen, P. N., Lowy, D. R., & Schiller, J. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5346 · Cited by 252
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., Decarvalho, N. S., et al. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000154423.27940.68 · Cited by 247
Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529
Evans, J. T., Cluff, C. W., Johnson, D. A., Lacy, M. J., Persing, D. H., & Baldridge, J. R. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.219 · Cited by 243
Antigen presentation by monocytes and monocyte-derived cells
Randolph, G. J., Jakubzick, C., & Qu, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.010 · Cited by 237
(How) do aluminium adjuvants work?
BREWER, J. (2006) · Immunology Letters · doi:10.1016/j.imlet.2005.08.002 · Cited by 236
Descamps, D., Hardt, K., Spiessens, B., Izurieta, P., Verstraeten, T., Breuer, T., & Dubin, G. (2009) · Human Vaccines · doi:10.4161/hv.5.5.7211 · Cited by 199
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 196
New hepatitis B vaccine formulated with an improved adjuvant system
Kundi, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.133 · Cited by 193
Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells
Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F., Goldman, M., & Dubois, P. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.926 · Cited by 183
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J., & Moser, M. (2000) · International Immunology · doi:10.1093/intimm/12.6.807 · Cited by 182
Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A
Martin, M., Michalek, S. M., & Katz, J. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2498-2507.2003 · Cited by 178
Verstraeten, T., Descamps, D., David, M., Zahaf, T., Hardt, K., Izurieta, P., Dubin, G. O., & Breuer, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.049 · Cited by 155
Rudolf, M. P., Fausch, S. C., Silva, D. M. D., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5917 · Cited by 155
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · Cited by 145
Cutting Edge: T Cells Respond to Lipopolysaccharide Innately via TLR4 Signaling
Zanin‐Zhorov, A., Tal, G., Cahalon, L., Cohen-Sfady, M., Pevsner‐Fischer, M., Lider, O., & Cohen, I. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.41 · Cited by 118
Vaccine Adjuvants Alter TCR-Based Selection Thresholds
Malherbe, L. P., Mark, L., Fazilleau, N., McHeyzer‐Williams, L. J., & McHeyzer‐Williams, M. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.014 · Cited by 106
Yang, R., Murillo, F., Delannoy, M. J., Blosser, R. L., Yutzy, W. H., Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., & Roden, R. B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7912 · Cited by 96
Frost, R. A., Nystrom, G. J., & Lang, C. H. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00010.2004 · Cited by 61
Lenz, P., Lowy, D. R., & Schiller, J. T. (2005) · European Journal of Immunology · doi:10.1002/eji.200425547 · Cited by 61
Garçon, N., Mechelen, M. V., & Wettendorff, M. A. (2006) · Elsevier eBooks · doi:10.1016/b978-012088403-2/50011-3 · Cited by 35
Self-citationTiberio, L., Fletcher, L. D., Eldridge, J. H., & Duncan, D. D. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.019 · Cited by 34
Toll-like receptors and IFN-α: partners in autoimmunity
Colonna, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29879 · Cited by 34
Cited by
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Mechanisms of Action of Adjuvants
Awate, S., Babiuk, L. A., & Mutwiri, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00114 · Cited by 732
Lucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
Metadata
- Authors
- Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., Larocque, D., Van Mechelen, M., & Garçon, N.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6186-6197
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2096729904
- Cited by
- 758
- References
- 61
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.